Celon Pharma S.A. (WSE:CLN)
22.80
+0.60 (2.70%)
Oct 3, 2025, 5:00 PM CET
Celon Pharma Revenue
Celon Pharma had revenue of 55.82M PLN in the quarter ending June 30, 2025, a decrease of -14.94%. This brings the company's revenue in the last twelve months to 206.22M, down -0.78% year-over-year. In the year 2024, Celon Pharma had annual revenue of 205.55M, down -4.25%.
Revenue (ttm)
206.22M
Revenue Growth
-0.78%
P/S Ratio
5.95
Revenue / Employee
363.05K
Employees
558
Market Cap
1.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 205.55M | -9.12M | -4.25% |
Dec 31, 2023 | 214.66M | 20.78M | 10.72% |
Dec 31, 2022 | 193.89M | -2.20M | -1.12% |
Dec 31, 2021 | 196.09M | 38.64M | 24.54% |
Dec 31, 2020 | 157.45M | 55.20M | 53.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.17B |
NEUCA | 13.04B |
Synektik Spólka Akcyjna | 623.20M |
Voxel | 560.38M |
Selvita | 373.90M |
Centrum Medyczne ENEL-MED | 789.78M |
Ryvu Therapeutics | 130.10M |
Scope Fluidics | 720.00K |
Celon Pharma News
- 7 months ago - Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL'36), a Novel Once-Daily Treatment of Levodopa-Induced Dyskinesia in Parkinson's Disease - Benzinga